Zevra Therapeutics Chief Medical Officer Resigns
Zevra Therapeutics announced that its chief medical officer, Adrian Quartel, will step down from his position due to personal reasons, effective July 3. Quartel will continue to support the company in a consulting capacity through December 31, while Zevra conducts a search for its next medical chief. The company noted that its upcoming regulatory milestones, including the European review of arimoclomol for Niemann-Pick disease, remain on track.
